1[1]World Health Organization.Atlas of Heart Disease and Stroke.2005.
2[2]中华医学会糖尿病学分会.中国脑血管病防治指南[M].北京:北京大学医学出版社,2005.
3[3]Baird TA,Parsons MW,Barber PA,et al.The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome[J].J Clin Neurosci,2002,9:618-626.
4[4]Ivey FM,Ryan AS,Hafer-Macko CE,et al.High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke[J].Cerebrovasc Dis,2006,22:368-371.
5[5]Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose.tolerance:an important predictor of long-term outcome after myocardial infarction[J].Eur Heart J,2004,25:1990-1997.
6[6]Bruno A,Williams L S,Kent TA.How important is hyperglycemia during acute brain infarction?[J].Neurologist,2004,10:195-200.
7[7]Baird TA,Parsons MW,Phanh T,et al.Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome[J].Stroke,2003,34:2208-2214.
8[8]Matz K,Keresztes K,Tatschl C,et al.Disorders of glucose metabolism in acute stroke patients.An underrecognised problem[J].Diabetes Care,2006,29:792-797.
2Temelkova-Kurktschiev T, Henkel E, Schaper F, et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia and underestimated evil? Exp Clin Endocrinol Diabetes, 2000,108:93-99.
3Pickup JC, Crook MA. Is type Ⅱ diabetes mellitus a disease of the innate immune system? Diabetologia, 1998,41:1241-1248.
4Pickup JC, Mattock MB, Chuseney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292.
5McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046.
6Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
7Ebeling P, Tepppo AM, Koistinen HA, et al. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins with type Ⅱ diabetes. Diabetologia, 1999,42:1433-1438.
8Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science, 2001,293:1673-1677.
6Cannon RO 3rd.Role of nitric oxide in cardiovscular disease:focus on the endothlium[J].Clin Chem,1998,44(8 Pt 2):1 809-1 819.
7Devaraj S,Venugopal S K,Sinnh U,et al.Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha}and-{beta}[J].Diabetes,2005,54(1):85-91.
8Polat K,Kara S,Latifoglu F,et al.Pattern detection of atherosclerosis from carotid artery Doppler signals using Fuzzy Weighted Pre-Processing and Least Square Support Vector Machine[J].Ann Biomed Eng,2007,35(5):724-732.
9Rubinstein S M,Peerdeman S M,van Tulder M W,et al.A systematic review of the risk factors for cervical artery dissection[J].Stroke,2005,36:1 575-1 580.
10Schlager O,Exner M,Mlekusch W,et al.C-reactive protein predicts future cardiovascular events in patients with carotid stenosis[J].Stroke,2007,38(4):1 263-1 268.
